Open spinal dysraphism with a posterior meningocele

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:645270
Who is this for?
Show terms as
View depth
8Treatment centers

Where are you in your journey?

UniteRare data is compiled from authoritative primary sources (FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, NORD), then processed through automated and AI-assisted extraction pipelines.
Report missing data

What is Open spinal dysraphism with a posterior meningocele?

Open spinal dysraphism with a posterior meningocele is a rare congenital neural tube defect in which the spinal canal fails to close properly during embryonic development, resulting in a sac-like protrusion (meningocele) through a defect in the posterior vertebral arches. The meningocele contains cerebrospinal fluid and meninges (the protective membranes surrounding the spinal cord) but typically does not contain neural tissue (spinal cord or nerve roots) within the herniated sac. Because this is classified as an open dysraphism, the defect is exposed or covered only by a thin membrane rather than intact skin, which distinguishes it from closed spinal dysraphisms. The condition is apparent at birth and primarily affects the central nervous system and musculoskeletal system. Clinical features may include a visible cystic mass along the posterior midline of the back, and depending on the level and extent of the defect, patients may experience varying degrees of neurological impairment. Because neural elements are generally not displaced into the sac, neurological deficits tend to be less severe than in myelomeningocele; however, complications such as cerebrospinal fluid leakage, risk of meningitis, tethered cord, and hydrocephalus may still occur. Orthopedic abnormalities and bladder or bowel dysfunction can also be present in some cases. Treatment is primarily surgical, with early postnatal repair of the defect to prevent infection, protect neural structures, and restore the integrity of the spinal covering. Surgical closure is typically performed within the first days of life, especially in open defects where the risk of central nervous system infection is high. Long-term management may involve multidisciplinary follow-up including neurosurgery, urology, orthopedics, and rehabilitation to monitor for complications such as tethered cord syndrome or hydrocephalus. Prenatal folic acid supplementation is a well-established preventive measure that reduces the overall risk of neural tube defects.

Inheritance
Multifactorial
Caused by a mix of several genes and environmental factors
Age of Onset
Neonatal
Begins at or shortly after birth (first 4 weeks)
Orphanet ↗NORD ↗

Treatments

Source: openFDA + DailyMed · NDA / BLA labels with structured indications · refreshed weekly

No FDA-approved treatments are currently listed for Open spinal dysraphism with a posterior meningocele.

View clinical trials →

Source: ClinicalTrials.gov · synced daily · phases, status, and PI names normalized at ingest

No actively recruiting trials found for Open spinal dysraphism with a posterior meningocele at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Open spinal dysraphism with a posterior meningocele community →

Source: NPI Registry + PubMed · trial PI roles cross-referenced with ClinicalTrials.gov · ranked by match score (publications + PI activity + community signal)

No specialists are currently listed for Open spinal dysraphism with a posterior meningocele.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers

Source: NORD Rare Disease Centers + NIH Undiagnosed Diseases Network (UDN) · centers verified active within last 12 months

🏨 Children's

Children's Hospital Colorado Rare Disease Program

Children's Hospital Colorado

📍 Aurora, CO

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Boston Children's Hospital Rare Disease Program

Boston Children's Hospital

📍 Boston, MA

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

🏨 Children's

Ann & Robert H. Lurie Children's Hospital Genetics

Lurie Children's Hospital

📍 Chicago, IL

👤 Boston Children's Hospital Rare Disease Program

🏥 NORD

Cincinnati Children's Hospital Medical Center

Cincinnati Children's

📍 Cincinnati, OH

👤 Boston Children's Hospital Rare Disease Program

🏨 Children's

Nationwide Children's Hospital Rare Disease Center

Nationwide Children's Hospital

📍 Columbus, OH

👤 Boston Children's Hospital Rare Disease Program

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

Travel Grants

No travel grants are currently matched to Open spinal dysraphism with a posterior meningocele.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Open spinal dysraphism with a posterior meningoceleForum →

No community posts yet. Be the first to share your experience with Open spinal dysraphism with a posterior meningocele.

Start the conversation →

Latest news about Open spinal dysraphism with a posterior meningocele

Source: PubMed + NIH RePORTER + openFDA + clinical-journal RSS · last 30 days · disease-tagged at ingest by AI extraction with human QC

No recent news articles for Open spinal dysraphism with a posterior meningocele.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Open spinal dysraphism with a posterior meningocele

What is Open spinal dysraphism with a posterior meningocele?

Open spinal dysraphism with a posterior meningocele is a rare congenital neural tube defect in which the spinal canal fails to close properly during embryonic development, resulting in a sac-like protrusion (meningocele) through a defect in the posterior vertebral arches. The meningocele contains cerebrospinal fluid and meninges (the protective membranes surrounding the spinal cord) but typically does not contain neural tissue (spinal cord or nerve roots) within the herniated sac. Because this is classified as an open dysraphism, the defect is exposed or covered only by a thin membrane rather

How is Open spinal dysraphism with a posterior meningocele inherited?

Open spinal dysraphism with a posterior meningocele follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Open spinal dysraphism with a posterior meningocele typically begin?

Typical onset of Open spinal dysraphism with a posterior meningocele is neonatal. Age of onset can vary across affected individuals.

Frequently asked questions about Open spinal dysraphism with a posterior meningocele

Auto-generated from canonical disease facts (Orphanet, OMIM, ClinicalTrials.gov, openFDA, NPPES). Not a substitute for clinical guidance.

  1. What is Open spinal dysraphism with a posterior meningocele?

    Open spinal dysraphism with a posterior meningocele is a rare disease catalogued in international rare-disease ontologies (Orphanet ORPHA:645270). It is typically inherited as multifactorial. Age of onset is generally neonatal. For verified primary sources, see the UniteRare Open spinal dysraphism with a posterior meningocele page.

  2. How is Open spinal dysraphism with a posterior meningocele inherited?

    Open spinal dysraphism with a posterior meningocele follows multifactorial inheritance. Genetic counseling is recommended for affected families to understand recurrence risk in offspring and the likelihood of unaffected siblings being carriers. Variants in the underlying gene(s) may be identified via clinical genetic testing.

  3. Are there FDA-approved treatments for Open spinal dysraphism with a posterior meningocele?

    Approved treatments for Open spinal dysraphism with a posterior meningocele are tracked from openFDA and DailyMed primary sources. Many rare diseases have no specific FDA-approved therapy; for those, supportive care and management of complications form the basis of clinical care. Orphan-drug-designation status is noted where applicable.

  4. Are there clinical trials for Open spinal dysraphism with a posterior meningocele?

    Active clinical trials for Open spinal dysraphism with a posterior meningocele are tracked daily from ClinicalTrials.gov. Trial availability changes frequently; check the UniteRare trial listings for the current count and recruitment status. Sponsors of rare-disease research often welcome inquiries even when a trial is not actively recruiting at a given moment.

  5. How do I find a specialist for Open spinal dysraphism with a posterior meningocele?

    Verified Open spinal dysraphism with a posterior meningocele specialists are identified through ClinicalTrials.gov principal-investigator records, peer-reviewed publication authorship (via PubMed), and the NPPES NPI registry. NORD-designated Centers of Excellence and NIH-affiliated rare-disease clinics are also tracked. UniteRare's specialist directory is updated continuously as new evidence becomes available.

See full Open spinal dysraphism with a posterior meningocele page for complete clinical details, sources, and verified-specialist listings.

Cite this page

Select a citation format above to view and copy.